BioIVT has announced a significant milestone with the opening of a new office and state-of-the-art laboratory in Woodbury, New York.
The expansion reinforces the biospecimen solutions provider’s commitment to supporting life-saving research both within New York’s growing scientific community and internationally.
The opening comes as New York solidifies its reputation as a key player in the biotechnology sector.
With a recent $620m state grant driving innovation, the region is experiencing a surge in investment and collaboration across the life sciences industry.
BioIVT’s Woodbury facility highlights the strength of New York’s vibrant biotech ecosystem while serving as a global hub for delivering high-quality biospecimens to researchers around the world.
The grand opening celebration will take place on 18 September 2025 with a ribbon-cutting ceremony, company social event and local government in attendance.
Distinguished guests, including Dr Richard Haigh, CEO at BioIVT, will share remarks about the company’s vision and what’s possible through this new office space.
“With our new Woodbury facility, BioIVT is deepening its support for the scientific research community, amplifying our global reach and impact, as well as our commitment to strengthening the local economy,” said Haigh.
“The grand opening will be a moment to celebrate the company’s vision for the future, its positive impact on the local community that’s highly invested in innovation and our team’s dedication to advancing the life sciences sector as a whole.”
The new office is located at 175 Crossways Park Drive West, Suite 200, Woodbury, NY 11797.
In addition to this site, BioIVT has 27 global sites providing unmatched sourcing and exceptional services.